ArticleScientific reports2026
Molecular characterization of directly reprogrammed neurons from human fibroblasts using single cell RNA sequencing.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Direct neuronal reprogramming offers a promising strategy to generate functional neurons from somatic cells without passing through a pluripotent state. However, the cellular heterogeneity and molecular transitions underlying this process remain incompletely understood in human cells. Here, we transduced human dermal fibroblasts with lentiviral short hairpin RNA targeting polypyrimidine tract-binding protein 1 (PTBP1) and performed single-cell RNA sequencing (scRNA-seq) at day 14 post-transduction. PTBP1 knockdown was associated with neurogenic transcription factor upregulation and the emergence of neuronal morphology, with conversion efficiency reaching approximately 20% by week 2. scRNA-seq revealed a progression from fibroblasts toward transcriptionally distinct immature and mature neuronal populations, and pseudotime analysis provided a descriptive ordering of cells along divergent transcriptional gradients that reflect transitions toward either neuronal or myofibroblast-like states. Using an analytic framework designed to ensure statistical robustness in single-sample data, we identified transcription factors that reliably distinguish mature from immature neuronal lineages. These findings provide mechanistic insight into barriers to neuronal maturation and highlight potential molecular targets that may improve the efficiency of direct neuronal reprogramming in human cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.